Tackling cancer in the developing world
29 Jun 2016
Tackling cancer in the developing world
Reducing inequalities in global health risk
Results from the EURO-SKI cessation trial of TKIs in CML
Editor's ASCO 2016 Roundup
Multiple myeloma highlights from EHA 2016
Ten years of letrozole improves survival and quality of life in early-diagnosed breast cancer.
Global drug pricing: How cost-effective is bevacizumab?
Phase I study of sapacitabine and seliciclib in patients with advanced solid tumours
METEOR trial: cabozantinib vs everolimus in advanced renal cell carcinoma
Patient engagement in The Metastatic Breast Cancer Project
Hypo-fractionation of prostate cancer radiotherapy
Use of novel agents in childhood ALL